Clinical trial–derived risk model may not generalize to real-world patients with acute coronary syndrome☆
To access this article, please choose from the options below
☆ Supported by the Canadian Heart Research Centre and Key Pharmaceuticals, Division of Schering Canada Inc.
PII: S0002-8703(04)00191-7
doi:10.1016/j.ahj.2004.02.014
© 2004 Elsevier Inc. All rights reserved.
